Skip to main content
Premium Trial:

Request an Annual Quote

Pressure BioSciences Posts Flat Q1 Revenues, Doubles Loss

NEW YORK (GenomeWeb News) – Pressure BioSciences yesterday reported first quarter revenue that was virtually flat with the 2007 first quarter and a net loss than more than doubled year over year.
The South Easton, Mass.-based maker of pressure cycling products for biomolecular research applications reported revenues of $132,376 for the three-month period ended March 31, compared to revenues of $131,621 for the first quarter of 2007. The company noted that it installed seven PCT Sample Preparation Systems during the quarter.
Pressure Bio posted a net loss of $1.34 million, or $.61 per share, compared to a loss of $638,086, or $.31 per share, in the first quarter of 2007.
The firm’s R&D expenses increased slightly to $490,931 from $461,532 year over year, while SG&A costs rose 30.7 percent to $964,409 from $737,612.
Pressure Bio finished the quarter with $4.1 million in cash and cash equivalents.
Its shares were down 9.5 percent at $4.38 in Friday afternoon trade on the Nasdaq.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.